OncoSec Medical Valuation
| ONCSDelisted Stock | USD 0.06 0 3.63% |
OncoSec Medical seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of OncoSec Medical from analyzing the company fundamentals such as Shares Owned By Institutions of 5.83 %, shares outstanding of 5.96 M, and Return On Equity of -4.1 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that OncoSec Medical's price fluctuation is very steady at this time. Calculation of the real value of OncoSec Medical is based on 3 months time horizon. Increasing OncoSec Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the OncoSec stock is determined by what a typical buyer is willing to pay for full or partial control of OncoSec Medical. Since OncoSec Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of OncoSec Stock. However, OncoSec Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0584 | Real 0.0555 | Hype 0.06 |
The intrinsic value of OncoSec Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence OncoSec Medical's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of OncoSec Medical helps investors to forecast how OncoSec stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of OncoSec Medical more accurately as focusing exclusively on OncoSec Medical's fundamentals will not take into account other important factors: OncoSec Medical Total Value Analysis
OncoSec Medical is now forecasted to have valuation of 5.6 M with market capitalization of 1.65 M, debt of 6.17 M, and cash on hands of 19.48 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the OncoSec Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.6 M | 1.65 M | 6.17 M | 19.48 M |
OncoSec Medical Asset Utilization
One of the ways to look at asset utilization of OncoSec is to check how much profit was generated for every dollar of assets it reports. OncoSec Medical holds a negative application of assets of -0.93 pct., losing $0.009284 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of OncoSec Medical shows how discouraging it operates for each dollar spent on its assets.OncoSec Medical Ownership Allocation
OncoSec Medical has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.OncoSec Medical Profitability Analysis
Net Loss for the year was (34.18 M) with profit before overhead, payroll, taxes, and interest of 0.About OncoSec Medical Valuation
The delisted stock valuation mechanism determines OncoSec Medical's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of OncoSec Medical based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of OncoSec Medical. We calculate exposure to OncoSec Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of OncoSec Medical's related companies.OncoSec Medical Incorporated, a late-stage immuno-oncology company, focuses on designing, developing, commercializing intra-tumoral DNA-based therapeutics to stimulate and augment anti-tumor immune responses for the treatment of cancer. The company was incorporated in 2008 and is headquartered in Pennington, New Jersey. Oncosec Medical operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 54 people.
OncoSec Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as OncoSec Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1.8 M | |
| Forward Price Earnings | 8.6655 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.
Other Consideration for investing in OncoSec Stock
If you are still planning to invest in OncoSec Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the OncoSec Medical's history and understand the potential risks before investing.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |